cheaptrix/billsum-US_congress_and_house huggingface dataset:
Opioid Screening and Chronic Pain Management Alternatives for Seniors Act

To amend title XVIII of the Social Security Act to require a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examination. 1. Short title This Act may be cited as the Opioid Screening and Chronic Pain Management Alternatives for Seniors Act 2. Requiring a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examination (a) In general Section 1861(ww) of the Social Security Act ( 42 U.S.C. 1395x(ww) (1) in paragraph (1), by inserting and a review of current opioid prescriptions and screening for opioid use disorder (as defined in paragraph (4)), but does not include (2) by adding at the end the following new paragraph: (4) (A) For purposes of paragraph (1), the term a review of current opioid prescriptions and screening for opioid use disorder (i) a review by a physician or qualified non-physician practitioner of all current prescriptions of the individual; and (ii) in the case of an individual determined by the review of a physician or qualified non-physician practitioner under subparagraph (A) to have a current prescription for opioids for chronic pain that has been prescribed for a minimum period of time (as specified by the Secretary)— (I) a review by the physician or practitioner of the potential risk factors to the individual for opioid use disorder; (II) an evaluation by the physician or practitioner of pain of the individual; (III) the provision of information regarding non-opioid treatment options for the treatment and management of any chronic pain of the individual; and (IV) if determined necessary by the physician or practitioner based on the results of the review and evaluation conducted as described in this paragraph, an appropriate referral by the physician or practitioner for additional treatment. (B) For purposes of this paragraph, the term qualified non-physician practitioner . (b) Effective date The amendments made by subsection (a) shall apply with respect to initial preventive physical examinations furnished on or after January 1, 2020. June 12, 2018 Reported from the Committee on Energy and Commerce June 12, 2018 The Committee on Ways and Means

Summary: Opioid Screening and Chronic Pain Management Alternatives for Seniors Act This bill requires the initial examination for new Medicare enrollees to include a review of current opioid prescriptions and an opioid use disorder screening.
Ensuring Complete Coverage of Medication-Assisted Treatment Act

To amend title XIX of the Social Security Act to require States to include under their State Medicaid plans coverage for medication-assisted treatment, and for other purposes. 1. Short title This Act may be cited as the Ensuring Complete Coverage of Medication-Assisted Treatment Act 2. Requirement for State Medicaid plans to provide coverage for medication-assisted treatment (a) Requirement for State Medicaid plans To provide coverage for medication-Assisted treatment Section 1902(a)(10)(A) of the Social Security Act ( 42 U.S.C. 1396a(a)(10)(A) and (28) (28), and (29) (b) Inclusion of medication-Assisted treatment as medical assistance Section 1905(a) of the Social Security Act ( 42 U.S.C. 1396d(a) (1) in paragraph (28), by striking and (2) by redesignating paragraph (29) as paragraph (30); and (3) by inserting after paragraph (28) the following new paragraph: (29) beginning, subject to paragraph (2) of subsection (ee), January 1, 2020, medication-assisted treatment (as defined in paragraph (1) of such subsection); and . (c) Medication-Assisted treatment defined; Waivers Section 1905 of the Social Security Act ( 42 U.S.C. 1396d (ee) Medication-Assisted treatment defined; Waivers (1) Medication-assisted treatment defined For purposes of subsection (a)(29), the term medication-assisted treatment (A) means all drugs approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 42 U.S.C. 262 (B) includes, with respect to the provision of such drugs and biological products, counseling services and behavioral therapy. (2) Waivers For purposes of subsection (a)(29), the Secretary may grant a waiver, with respect to a State, to delay the application of such subsection if the State submits a waiver request that includes the following: (A) The reasoning for such waiver. (B) A timeline for the State to implement the requirement of such subsection. (C) A review of any prior authorization program and any drug utilization management program established by the State under the State plan (or a waiver of such plan) to assess the types of barriers that individuals encounter in accessing medication-assisted treatment (as defined in paragraph (1)) under such plan (or waiver). (D) Any other information that the Secretary may require. . (d) Effective date (1) In general Subject to paragraph (2), the amendments made by this section shall take effect with respect to medical assistance provided on or after January 1, 2020. (2) Exception for State legislation In the case of a State plan under title XIX of the Social Security Act ( 42 U.S.C. 1396

Summary: Ensuring Complete Coverage of Medication-Assisted Treatment Act This bill requires coverage of medication-assisted treatment, which is used to treat substance-use disorders, under Medicaid.
SAFETY Act of 2018

To amend the Federal Food, Drug, and Cosmetic Act to authorize the Secretary of Health and Human Services to consider the potential for misuse and abuse when determining whether to approve certain drugs, and for other purposes. 1. Short title This Act may be cited as the Saving American Families through Efficacy and Trusted Ways Act of 2018 SAFETY Act of 2018 2. Consideration of potential for misuse and abuse required for drug approval (a) In general Section 505(d) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(d) (1) in the first sentence— (A) by striking or (7) (7) (B) by inserting ; or (8) if the drug is or contains a controlled substance for which a listing in any schedule is in effect under the Controlled Substances Act or that is permanently scheduled pursuant to section 201 of such Act, on the basis of information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, the drug is unsafe for use due to the risks of abuse or misuse or there is insufficient information to show that the drug is safe for use considering such risks; he shall issue an order refusing to approve the application (2) in the second sentence, by striking (6) (8) (b) Withdrawal authority Section 505(e) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(e) (1) by striking or (5) (5) (2) by inserting the following: ; or (6) that, in the case of a drug that is or contains a controlled substance for which a listing in any schedule is in effect under the Controlled Substances Act or that is permanently scheduled pursuant to section 201 of such Act, on the basis of new information before him with respect to such drug, evaluated together with the information available to him when the application was approved, that the drug is unsafe for use due to the risks of abuse or misuse of a material fact (c) Rule of construction Nothing in the amendments made by this section shall be construed to limit or narrow, in any manner, the meaning or application of the provisions of paragraphs (1), (2), (3), (4), (5), and (7) of section 505(d) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(d) 21 U.S.C. 355(e)

Summary: Saving American Families through Efficacy and Trusted Ways Act of 2018 or the SAFETY Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to refuse or withdraw approval for a new drug application if the drug is unsafe due to the risk of abuse or misuse.
Post-Surgical Injections as an Opioid Alternative Act

To amend title XVIII of the Social Security Act to provide for modifications in payment for certain outpatient surgical services. 1. Short title This Act may be cited as the Post-Surgical Injections as an Opioid Alternative Act 2. Modification of payment for certain outpatient surgical services (a) Freeze of payment for certain services furnished in ambulatory surgical centers Section 1833(i)(2) of the Social Security Act ( 42 U.S.C. 1395l(i)(2) (F) (i) With respect to a targeted procedure (as defined in clause (ii)) furnished during 2020 or a subsequent year (before 2025) to an individual in an ambulatory surgical center, the payment amount for such procedure that would otherwise be determined under the revised payment system under subparagraph (D), without application of this subparagraph, shall be equal to the payment amount for such procedure furnished in 2016. (ii) For purposes of clause (i), the term targeted procedure (iii) This subparagraph shall not be applied in a budget-neutral manner. . (b) Data collection (1) In general The Comptroller General shall collect data relating to the cost differential between targeted procedures (as defined in section 1833(i)(2)(F)(ii) of the Social Security Act, as added by subsection (a)) that are performed in a hospital operating room and such procedures that are performed in an office setting within a hospital in order to determine whether such procedures are being properly coded for claims, based on setting, for payment under section 1833(i)(2)(D) of the Social Security Act ( 42 U.S.C. 1395l(i)(2)(D) 42 U.S.C. 1395l(t)(2)(A) (2) Report Not later than 4 years after the date of the enactment of this Act, the Comptroller General shall submit a report to the Committee on Energy and Commerce and the Committee on Ways and Means of the House of Representatives and the Committee on Finance of the Senate containing— (A) a determination of whether procedures described in paragraph (1) are being properly coded for claims, based on setting, for payment under section 1833(i)(2)(D) of the Social Security Act ( 42 U.S.C. 1395l(i)(2)(D) (B) recommendations on any changes the Comptroller General determines are needed in the classification system for covered outpatient department services (as described in section 1833(t)(2)(A) of the Social Security Act ( 42 U.S.C. 1395l(t)(2)(A) (c) Study Not later than 3 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall conduct a study and submit to Congress a report on the extent to which procedures described in section 1833(i)(2)(F)(ii) of the Social Security Act, as added by subsection (a), are effective at preventing the need for opioids for individuals furnished such procedures. June 13, 2018 Reported from the Committee on Energy and Commerce June 13, 2018 Committee on Ways and Means

Summary: Post-Surgical Injections as an Opioid Alternative Act This bill temporarily freezes Medicare payment at 2016 levels for specified spinal surgery outpatient procedures that are conducted in ambulatory surgical centers.
To designate certain amounts authorized to be appropriated for the provision by the Secretary of Veterans Affairs of hospital care and medical services in non-Department of Veterans Affairs facilities pursuant to contracts as changes in concepts and definitions for certain budgetary purposes, and for other purposes.

To designate certain amounts authorized to be appropriated for the provision by the Secretary of Veterans Affairs of hospital care and medical services in non-Department of Veterans Affairs facilities pursuant to contracts as changes in concepts and definitions for certain budgetary purposes, and for other purposes. 1. Designation of certain amounts authorized to be appropriated for the Department of Veterans Affairs as changes in concepts and definitions (a) In general Amounts authorized to be appropriated to carry out section 1703 of title 38, United States Code, shall be considered changes in concepts and definitions pursuant to section 251(b)(1) of the Balanced Budget and Emergency Deficit Control Act of 1985 ( 2 U.S.C. 901(b)(1) (b) Adjustment of fiscal year 2019 discretionary spending limits Within 15 days of the publication of a final rule in the Federal Register promulgating the regulations pursuant to section 101(c) of this Act, the Office of Management and Budget shall further adjust the fiscal year 2019 discretionary spending limits to reflect the impact of those regulations, as estimated by the Department of Veterans Affairs, on the discretionary appropriations that are specified for those authorizations of appropriations in the Budget that the President submitted for that fiscal year under section 1105 of title 31 United States Code, and shall provide written notification to the Congress of such further adjustments. (c) Report to Congress Not later than 10 days after the date each year on which the President submits the budget request under section 1105 of title 31 United States Code, and also 10 days after the publication of the final rule previously referenced in this section, the Secretary of Veterans Affairs shall submit to the Committees on Appropriations of both Houses of Congress a report detailing the estimates of the resources required by the Department for those authorizations of appropriations, as forecast using the Enrollee Health Care Projections Model, or other methodologies used by the Department. (d) Adjustment of future discretionary spending limits For each fiscal year, the Office of Management and Budget shall further adjust the discretionary spending limits in section 251(c) of the Balanced Budget and Emergency Deficit Control Act of 1985 ( 2 U.S.C. 901(c)

Summary: This bill modifies the rules for estimating the budgetary impact of funds authorized to be appropriated to the Department of Veterans Affairs for contracts for hospital care and medical services in non-department facilities. The bill also requires related adjustments to discretionary spending limits.
21st Century Tools for Pain and Addiction Treatment Act

To require the Secretary of Health and Human Services to issue guidance with respect to the expedited approval of certain drugs, and for other purposes. 1. Short title This Act may be cited as the 21st Century Tools for Pain and Addiction Treatment Act 2. Clarifying FDA regulation of non-addictive pain and addiction therapies (a) Public meetings Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall hold not less than one public meeting to address the challenges and barriers of developing non-addictive medical products intended to treat pain or addiction, which may include— (1) the application of novel clinical trial designs (consistent with section 3021 of the 21st Century Cures Act ( Public Law 114–255 21 U.S.C. 355g 21 U.S.C. 360bbb–8c (2) the application of eligibility criteria under sections 506 and 515B of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 356 (b) Guidance Not later than one year after the public meetings are conducted under subsection (a) the Secretary shall issue one or more final guidance documents, or update existing guidance documents, to help address challenges to developing non-addictive medical products to treat pain or addiction. Such guidance documents shall include information regarding— (1) how the Food and Drug Administration may apply sections 506 and 515B of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 356 (A) may apply the eligibility criteria under such sections 506 and 515B to non-opioid or non-addictive medical products intended to treat pain or addiction; (B) considers the risk of addiction of controlled substances approved to treat pain when establishing unmet medical need; and (C) considers pain, pain control, or pain management in assessing whether a disease or condition is a serious or life-threatening disease or condition; and (2) the methods by which sponsors may evaluate acute and chronic pain, endpoints for non-addictive medical products intended to treat pain, the manner in which endpoints and evaluations of efficacy will be applied across and within review divisions, taking into consideration the etiology of the underlying disease, and the manner in which sponsors may use surrogate endpoints, intermediate endpoints, and real world evidence. (c) Medical product defined In this section, the term medical product 21 U.S.C. 321(g)(1) 42 U.S.C. 262(i) 21 U.S.C. 321(h)

Summary: 21st Century Tools for Pain and Addiction Treatment Act This bill requires the Food and Drug Administration (FDA)to revise how it will address the challenges and barriers of developing non-addictive medical products to treat pain or addiction.
Postoperative Opioid Prevention Act of 2018

To amend title XVIII of the Social Security Act to encourage the use of non-opioid analgesics for the management of post-surgical pain under the Medicare program, and for other purposes. 1. Short title This Act may be cited as the Postoperative Opioid Prevention Act of 2018 2. Medicare incentives for use of non-opioid analgesics in hospital outpatient departments and ambulatory surgical centers Section 1833(t)(6) of the Social Security Act ( 42 U.S.C. 1395l(t)(6) (1) in subparagraph (C)(i), by inserting or, in the case of an eligible non-opioid analgesic (as defined in subparagraph (J)), during a period of 5 years, 3 years, (2) by adding at the end the following new subparagraph: (J) Eligible non-opioid analgesic defined In this paragraph, the term eligible non-opioid analgesic (i) that is an analgesic that is not an opioid; (ii) that demonstrated substantial clinical improvement; and (iii) for which payment— (I) as an outpatient hospital service under this part was not being made as of the date of the enactment of this subparagraph; or (II) was being made under this paragraph as of such date. . June 13, 2018 Reported from the Committee on Energy and Commerce June 13, 2018 Committee on Ways and Means

Summary: Postoperative Opioid Prevention Act of 2018 This bill temporarily increases payment under Medicare for certain non-opioid analgesics that are used for pain management in hospital outpatient department services.
Agriculture Conservation Stamp Act

To provide for the issuance of a semipostal to support Department of Agriculture conservation programs, and for other purposes. 1. Short title This Act may be cited as the Agriculture Conservation Stamp Act 2. Department of Agriculture conservation programs semipostal (a) In general The United States Postal Service shall, for a 4-year period beginning no later than 12 months after the date of the enactment of this Act, issue a semipostal to benefit certain conservation programs authorized by the Department of Agriculture. (b) Requirements and authorities The issuance of such semipostal and the disposition of the amounts becoming available from the issuance of such semipostal shall be governed by section 416 of title 39, United States Code, except that the Department of Agriculture shall be the sole agency to which any amounts becoming available from the sale of such semipostal may be transferred under section 416(d)(1) of such title. The Department shall use the amounts so transferred exclusively for programs authorized under title XII of the Food Security Act of 1985 ( 16 U.S.C. 3801 (c) Definition of semipostal In this section, the term semipostal

Summary: Agriculture Conservation Stamp Act This bill requires the U.S. Postal Service (USPS) to issue for a four-year period a semipostal to benefit certain Department of Agriculture (USDA) conservation programs. (A semipostal is a postage stamp that is issued and sold by the USPS at a premium, in order to help provide funding for a cause that the USPS considers to be in the national public interest and appropriate.) USDA is the sole agency to which the USPS may transfer funds received from the sale of the semipostal. USDA must use the transferred funds exclusively for programs authorized under title XII (Conservation) of the Food Security Act of 1985.
ROOT for Mainstreet Businesses Act of 2018

To amend the Internal Revenue Code of 1986 to exclude from the definition of personal holding company income certain royalties and rents derived in the active conduct of a trade or business. 1. Short title This Act may be cited as the Removing Onerous Obstacles in the Tax code for Mainstreet Businesses Act of 2018 ROOT for Mainstreet Businesses Act of 2018 2. Certain royalties and rents derived in the active conduct of a trade or business not treated as personal holding company income (a) Royalties (1) In general Section 543(a)(1) and , and (F) royalties derived in the active conduct of a trade or business which are received from a person other than a related person (within the meaning of section 267). . (2) Copyright royalties Section 543(a)(4) of such Code is amended by inserting or to any amount derived in the active conduct of a trade or business which are received from a person other than a related person (within the meaning of section 267) active business computer software royalties (b) Rents (1) In general Section 543(b)(3) of such Code is amended by striking or , or (F) amounts derived in the active conduct of a trade or business which are received from a person other than a related person (within the meaning of section 267). . (2) Produced film rents Section 543(a)(5)(B) of such Code is amended by adding at the end the following: Such term shall not include any amount derived in the active conduct of a trade or business which are received from a person other than a related person (within the meaning of section 267). (c) Regulations Section 543 of such Code is amended by adding at the end the following new subsection: (e) Determination of whether royalties and rents are derived in the active conduct of a trade or business The Secretary shall prescribe regulations or other guidance providing for the treatment of rents, royalties, and other amounts described in subsections (a)(1)(F), (a)(4), (a)(5)(B), and (b)(3)(F) as being derived in the active conduct of a trade or business consistent with the regulations and other guidance providing for such treatment for purposes of section 954(c)(2)(A). . (d) Effective date The amendments made by this section shall apply to taxable years ending on or after the date of the enactment of this Act.

Summary: Removing Onerous Obstacles in the Tax code for Mainstreet Businesses Act of 2018 or the ROOT for Mainstreet Businesses Act of 2018 This bill amends the Internal Revenue Code to exclude from personal holding company income certain rents and royalties that are derived in the active conduct of a trade or business and are not received from a related person.
Educators Expense Deduction Modernization Act

To amend the Internal Revenue Code of 1986 to increase the deduction for certain expenses of elementary and secondary school teachers. 1. Short title This Act may be cited as the Educators Expense Deduction Modernization Act 2. Increase in deduction for certain expenses of elementary and secondary school teachers (a) In general Section 62(a)(2)(D) $250 $500 (b) Inflation adjustment Section 62(d)(3) of such Code is amended to read as follows: (3) Inflation adjustment In the case of any taxable year beginning after 2019, the $500 amount in subsection (a)(2)(D) shall be increased by an amount equal to— (A) such dollar amount, multiplied by (B) the cost-of-living adjustment determined under section 1(f)(3) for the calendar year in which the taxable year begins, determined by substituting calendar year 2018 calendar year 2016 . (c) Effective date The amendments made by this section shall apply with respect to taxable years beginning December 31, 2018.

Summary: Educators Expense Deduction Modernization Act This bill amends the Internal Revenue Code, with respect to the deduction from gross income for certain expenses of elementary and secondary school teachers, to: (1) increase from $250 to $500 the annual limit on the expenses that may be deducted, and (2) require the limit to be adjusted for inflation after 2019.